149 related articles for article (PubMed ID: 33024132)
1. Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer.
Kjær IM; Olsen DA; Brandslund I; Bechmann T; Jakobsen EH; Bogh SB; Madsen JS
Sci Rep; 2020 Oct; 10(1):16558. PubMed ID: 33024132
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study.
Kjær IM; Olsen DA; Brandslund I; Bechmann T; Jakobsen EH; Bogh SB; Madsen JS
Sci Rep; 2020 Apr; 10(1):6714. PubMed ID: 32317675
[TBL] [Abstract][Full Text] [Related]
3. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency.
Kjær IM; Olsen DA; Alnor A; Brandslund I; Bechmann T; Madsen JS
Clin Chem Lab Med; 2019 Nov; 57(12):1948-1955. PubMed ID: 31323001
[TBL] [Abstract][Full Text] [Related]
4. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract][Full Text] [Related]
5. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: a systematic review.
Kjaer IM; Bechmann T; Brandslund I; Madsen JS
Clin Chem Lab Med; 2018 Apr; 56(5):688-701. PubMed ID: 29194036
[TBL] [Abstract][Full Text] [Related]
7. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
[TBL] [Abstract][Full Text] [Related]
8. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of growth factors and activation of the EGFR system in breast cancer.
Olsen DA; Bechmann T; Østergaard B; Wamberg PA; Jakobsen EH; Brandslund I
Clin Chem Lab Med; 2012 Oct; 50(10):1809-18. PubMed ID: 23089711
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
Gonzalez-Conchas GA; Rodriguez-Romo L; Hernandez-Barajas D; Gonzalez-Guerrero JF; Rodriguez-Fernandez IA; Verdines-Perez A; Templeton AJ; Ocana A; Seruga B; Tannock IF; Amir E; Vera-Badillo FE
Cancer Treat Rev; 2018 Jan; 62():1-8. PubMed ID: 29126017
[TBL] [Abstract][Full Text] [Related]
12. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
[TBL] [Abstract][Full Text] [Related]
13. Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients.
Weidner N; Gasparini G
Breast Cancer Res Treat; 1994 Jan; 29(1):97-107. PubMed ID: 7517222
[TBL] [Abstract][Full Text] [Related]
14. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
15. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma.
Gasparini G; Boracchi P; Bevilacqua P; Mezzetti M; Pozza F; Weidner N
Breast Cancer Res Treat; 1994 Jan; 29(1):59-71. PubMed ID: 7912568
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
17. Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study.
Cetintas S; Tezcan G; Tunca B; Egeli U; Gokgoz MS; Cecener G
Bosn J Basic Med Sci; 2019 May; 19(2):172-179. PubMed ID: 30242807
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
Gao J; Ulekleiv CH; Halstensen TS
J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
[TBL] [Abstract][Full Text] [Related]
19. Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer.
Shetty P; Patil VS; Mohan R; D'souza LC; Bargale A; Patil BR; Dinesh US; Haridas V; Kulkarni SP
Ann Clin Biochem; 2017 Jul; 54(4):463-471. PubMed ID: 27496793
[TBL] [Abstract][Full Text] [Related]
20. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
